strategic-management

248 VIJAYA NARAPAREDDY
EXHIBIT 6 Pfizer’s Balance Sheet
(all numbers in thousands)
PERIOD ENDING 31-Dec-08 31-Dec-07 31-Dec-06
Assets
Current Assets
Cash and Cash Equivalents $ 2,122,000 3,406,000 1,827,000
Short Term Investments 22,433,000 22,686,000 26,400,000
Net Receivables 13,992,000 9,843,000 9,392,000
Inventory 4,529,000 5,416,000 6,111,000
Other Current Assets — 5,498,000 3,219,000
Total Current Assets 43,076,000 46,849,000 46,949,000
Long Term Investments 11,478,000 4,856,000 3,892,000
Property Plant and Equipment 13,287,000 15,734,000 16,632,000
Goodwill 21,464,000 21,382,000 20,876,000
Intangible Assets 17,721,000 20,498,000 24,350,000
Accumulated Amortization — — —
Other Assets 4,122,000 1,844,000 2,138,000
Deferred Long Term Asset Charges — 4,105,000 —
Total Assets $ 111,148,000 115,268,000 114,837,000
Liabilities
Current Liabilities
Accounts Payable 6,233,000 7,787,000 12,443,000
Short/Current Long Term Debt 9,320,000 5,825,000 2,434,000
Other Current Liabilities 11,456,000 8,223,000 6,512,000
Total Current Liabilities 27,009,000 21,835,000 21,389,000
Long Term Debt 14,531,000 7,314,000 5,546,000
Other Liabilities 8,909,000 13,299,000 8,529,000
Deferred Long Term Liability Charges 2,959,000 7,696,000 8,015,000
Minority Interest 184,000 114,000 —
Negative Goodwill — — —
Total Liabilities 53,592,000 50,258,000 43,479,000
Stockholders’ Equity
Misc. Stocks Options Warrants — — —
Redeemable Preferred Stock — — —
Preferred Stock 73,000 93,000 141,000
Common Stock 443,000 442,000 441,000
Retained Earnings 49,142,000 49,660,000 49,669,000
Treasury Stock (57,391,000) (56,847,000) (46,740,000)
Capital Surplus 70,283,000 69,913,000 69,104,000
Other Stockholders’ Equity (4,994,000) 1,749,000 (1,257,000)
Total Stockholders’ Equity 57,556,000 65,010,000 71,358,000
Total Liabilities and SE $ 111,148,000 115,268,000 114,837,000